Sun Pharma.Inds.

Part of MojoOne Strategy

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE044A01036
NSEID: SUNPHARMA
BSEID: 524715

INR

1,784.80

-12.45 (-0.69%)

BSENSE

Dec 16

BSE+NSE Vol: 2.47 lacs

Click here to access the older version

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,784.80",
    "chg": -12.45,
    "chgp": "-0.69%",
    "dir": -1,
    "prev_price": "1,797.25",
    "mcapval": "428,233.31 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Dec 16",
    "curr_time": "",
    "bse_nse_vol": "2.47 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 16, 2025",
    "traded_date_str": "2025 12 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3759775",
        "imagepath": "",
        "date": "2025-12-16 09:21:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.</p>\n                <p>Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-technical-momentum-shifts-amid-mixed-market-signals-3758316",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_technicaldot_3758316.png",
        "date": "2025-12-15 08:04:43",
        "description": "Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory."
      },
      {
        "title": "Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-upgraded-to-strong-buy-on-robust-fundamentals-and-technicals-3757140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3757140.png",
        "date": "2025-12-12 08:11:55",
        "description": "Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Shows Mixed Technical Momentum Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-technical-momentum-shifts-to-bullish-amid-strong-buy-upgrade-3757077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_technicaldot_3757077.png",
        "date": "2025-12-12 08:08:57",
        "description": "Sun Pharmaceutical Industries has exhibited a nuanced shift in its technical momentum, reflecting a blend of bullish signals on shorter timeframes and more cautious indications over longer periods. The stock’s recent price movements and technical indicators suggest a complex market assessment, with investors weighing near-term optimism against broader market trends."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3756096",
        "imagepath": "",
        "date": "2025-12-11 09:21:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, attracting institutional investors and index funds that track this benchmark. The company’s market capitalisation, standing at approximately ₹4,29,349 crore, places it firmly among India’s large-cap stocks, underscoring its influence on the overall index movement.</p>\n                <p>Being part of the Nifty 50 also means that Sun Pharma’s stock performance is closely monitored by market participants, with its price fluctuations contributing materially to the index’s daily changes. This status often results in increased trading volumes and a heightened focus on quarterly results and strategic deve..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-and-market-dynamics-3754930",
        "imagepath": "",
        "date": "2025-12-10 09:21:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. This membership not only signifies the company’s large-cap status but also integrates it into the core benchmark that guides many portfolio allocations across India’s equity markets. The company’s market capitalisation stands at approximately ₹4,25,270 crore, underscoring its substantial weight within the index and the Pharmaceuticals & Biotechnology sector.</p>\n\n                <p>Being part of the Nifty 50 means that Sun Pharmaceutical Industries is subject to the trading dynamics and rebalancing activities that accompany index ad..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3753145",
        "imagepath": "",
        "date": "2025-12-09 09:20:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the most influential companies shaping the Indian equity market landscape. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock experiences liquidity benefits and heightened trading volumes, factors that can influence price discovery and volatility.</p>\n                <p>Sun Pharma’s market capitalisation stands at approximately ₹4,30,645 crores, categorising it firmly as a large-cap entity. This scale supports its benchmark status and underpins its weighting within th..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-performance-3750484",
        "imagepath": "",
        "date": "2025-12-08 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company's market capitalisation stands at a substantial ₹4,33,080 crore, categorising it firmly as a large-cap stock. This status not only influences its weighting within the index but also impacts trading volumes and investor interest.</p>\n                <p>Being part of the benchmark index means that Sun Pharmaceutical Industries is often included in passive investment portfolios tracking the Nifty 50, which can lead to sustained demand for its shares. This inclusion also subjects the stock to scrutiny by market participants ..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-and-institutional-dynamics-3748004",
        "imagepath": "",
        "date": "2025-12-05 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Sun Pharmaceutical Industries among the elite group of companies that represent the Indian equity market’s large-cap segment. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for price discovery and market stability.</p>\n                <p>Sun Pharma’s market capitalisation stands at approximately ₹4,36,343 crore, categorising it firmly as a large-cap entity. This scale supports its benchmark status and influe..."
      }
    ],
    "total": 905,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 - Approval Of Proposal For Greenfield Project",
      "datetime": "02-Dec-2025",
      "details": "Intimation under Regulation 30 - Approval of proposal for Greenfield Project",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Dec-2025",
      "details": "Sun Pharma introduces Ilumya in India for the treatment of moderate-to-severe Plaque Psoriasis.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "26-Nov-2025",
      "details": "Press Release",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>550%</strong> dividend, ex-date: 07 Jul 25",
          "dt": "2025-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics

2025-12-16 09:21:01

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a prominent position within India’s equity market. This membership not only reflects the company’s substantial market capitalisation, currently standing at approximately ₹4,28,317.28 crores, but also underscores its influence on index movements and investor sentiment. The Nifty 50 serves as a benchmark for many institutional and retail investors, making the stock’s performance a barometer for the Pharmaceuticals & Biotechnology sector’s health.

Sun Pharma’s inclusion in this elite group ensures heightened visibility and liquidity, factors that often attract significant institutional participation. The company’s mark...

Sun Pharmaceutical Industries: Technical Momentum Shift Signals Mixed Market Sentiment

2025-12-15 08:04:43

Sun Pharmaceutical Industries has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across multiple timeframes. This development invites a closer examination of key technical indicators such as MACD, RSI, moving averages, and volume trends to understand the stock’s current market positioning and potential trajectory.

Sun Pharmaceutical Industries: Analytical Perspective Shift Highlights Key Investment Factors

2025-12-12 08:11:55

Sun Pharmaceutical Industries has recently undergone a revision in its market assessment, reflecting changes across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article explores the underlying data and market context that have influenced this shift, providing investors with a comprehensive understanding of the company’s current standing within the Pharmaceuticals & Biotechnology sector.

Sun Pharmaceutical Industries Shows Mixed Technical Momentum Amid Market Fluctuations

2025-12-12 08:08:57

Sun Pharmaceutical Industries has exhibited a nuanced shift in its technical momentum, reflecting a blend of bullish signals on shorter timeframes and more cautious indications over longer periods. The stock’s recent price movements and technical indicators suggest a complex market assessment, with investors weighing near-term optimism against broader market trends.

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-11 09:21:06

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, attracting institutional investors and index funds that track this benchmark. The company’s market capitalisation, standing at approximately ₹4,29,349 crore, places it firmly among India’s large-cap stocks, underscoring its influence on the overall index movement.

Being part of the Nifty 50 also means that Sun Pharma’s stock performance is closely monitored by market participants, with its price fluctuations contributing materially to the index’s daily changes. This status often results in increased trading volumes and a heightened focus on quarterly results and strategic deve...

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-10 09:21:00

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. This membership not only signifies the company’s large-cap status but also integrates it into the core benchmark that guides many portfolio allocations across India’s equity markets. The company’s market capitalisation stands at approximately ₹4,25,270 crore, underscoring its substantial weight within the index and the Pharmaceuticals & Biotechnology sector.

Being part of the Nifty 50 means that Sun Pharmaceutical Industries is subject to the trading dynamics and rebalancing activities that accompany index ad...

Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics

2025-12-09 09:20:55

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the most influential companies shaping the Indian equity market landscape. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock experiences liquidity benefits and heightened trading volumes, factors that can influence price discovery and volatility.

Sun Pharma’s market capitalisation stands at approximately ₹4,30,645 crores, categorising it firmly as a large-cap entity. This scale supports its benchmark status and underpins its weighting within th...

Sun Pharmaceutical Industries: Navigating Nifty 50 Membership and Market Dynamics

2025-12-08 09:21:04

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Sun Pharmaceutical Industries benefits from enhanced visibility and liquidity, factors that often attract institutional investors and index funds. The company's market capitalisation stands at a substantial ₹4,33,080 crore, categorising it firmly as a large-cap stock. This status not only influences its weighting within the index but also impacts trading volumes and investor interest.

Being part of the benchmark index means that Sun Pharmaceutical Industries is often included in passive investment portfolios tracking the Nifty 50, which can lead to sustained demand for its shares. This inclusion also subjects the stock to scrutiny by market participants ...

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-05 09:21:04

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Sun Pharmaceutical Industries among the elite group of companies that represent the Indian equity market’s large-cap segment. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for price discovery and market stability.

Sun Pharma’s market capitalisation stands at approximately ₹4,36,343 crore, categorising it firmly as a large-cap entity. This scale supports its benchmark status and influe...

View All News